Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction

Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction

BackgroundReports have shown that neoadjuvant concurrent chemoradiotherapy (nCRT) increases the R0 resection rate for patients with Siewert type II or III adenocarcinoma of the gastroesophageal junction (AEG). However, the long-term efficacy of nCRT for AEG patients remains unclear. In this multicen...

Full description

Bibliographic Details
Main Authors: Yuan Tian, Jun Wang, Xueying Qiao, Jun Zhang, Yong Li, Liqiao Fan, Zhidong Zhang, Xuefeng Zhao, Bibo Tan, Dong Wang, Peigang Yang, Qun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant chemoradiotherapy
potentially resectable
advanced
Siewert II and III
adenocarcinoma of esophagogastric junction
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.756440/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.756440/full

Similar Items